These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 32583853)

  • 1. The relationship between neutrophil-lymphocyte ratio and in-stent restenosis in superficial femoral artery.
    Yang Y; Ge F; Shen J; Song J; Xie J; Qu J; Mao X; Kuang Z; Wang X; Wu Y; Wang S; Xiao L
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32583853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A risk predictor of restenosis after superficial femoral artery stent implantation: relevance of mean platelet volume.
    Yang YB; Shen J; Wang SH; Song JB; Ge F; Xie JP; Qu JS; Mao XZ; Kuang ZC; Shang N; Wang X; Wu YJ; Yang F; Yuan Y; Wang H; Sun J; Fang J; Xiao L
    BMC Cardiovasc Disord; 2020 Aug; 20(1):361. PubMed ID: 32770951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravascular Ultrasound-Derived Stent Dimensions as Predictors of Angiographic Restenosis Following Nitinol Stent Implantation in the Superficial Femoral Artery.
    Miki K; Fujii K; Kawasaki D; Shibuya M; Fukunaga M; Imanaka T; Tamaru H; Sumiyoshi A; Nishimura M; Horimatsu T; Saita T; Okada K; Kimura T; Honda Y; Fitzgerald PJ; Masuyama T; Ishihara M
    J Endovasc Ther; 2016 Jun; 23(3):424-32. PubMed ID: 27044270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative inflammatory status as a predictor of primary patency after femoropopliteal stent implantation.
    Nakazawa KR; Wengerter SP; Power JR; Lookstein RA; Tadros RO; Ting W; Faries PL; Vouyouka AG
    J Vasc Surg; 2017 Jul; 66(1):151-159. PubMed ID: 28259571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paclitaxel-Eluting Balloon vs Standard Angioplasty to Reduce Restenosis in Diabetic Patients With In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Arteries: Three-Year Results of the DEBATE-ISR Study.
    Grotti S; Liistro F; Angioli P; Ducci K; Falsini G; Porto I; Ricci L; Ventoruzzo G; Turini F; Bellandi G; Bolognese L
    J Endovasc Ther; 2016 Feb; 23(1):52-7. PubMed ID: 26511896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of the neutrophil to lymphocyte ratio for prediction of in-stent restenosis in bifurcation lesions.
    Balli M; Taşolar H; Çetin M; Tekin K; Çağliyan ÇE; Türkmen S; Yilmaz M; Elbasan Z; Şahin DY; Çayli M
    Eur Rev Med Pharmacol Sci; 2015 May; 19(10):1866-73. PubMed ID: 26044233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laser Atherectomy for Treatment of Femoropopliteal In-Stent Restenosis.
    Armstrong EJ; Thiruvoipati T; Tanganyika K; Singh GD; Laird JR
    J Endovasc Ther; 2015 Aug; 22(4):506-13. PubMed ID: 26130385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High dose-rate brachytherapy for the treatment of lower extremity in-stent restenosis.
    Ho KJ; Devlin PM; Madenci AL; Semel ME; Gravereaux EC; Nguyen LL; Belkin M; Menard MT
    J Vasc Surg; 2017 Mar; 65(3):734-743. PubMed ID: 27986482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stent implantation in the superficial femoral artery: short thrombelastometry-derived coagulation times identify patients with late in-stent restenosis.
    Cvirn G; Hoerl G; Schlagenhauf A; Tafeit E; Brodmann M; Juergens G; Koestenberger M; Gary T
    Thromb Res; 2012 Sep; 130(3):485-90. PubMed ID: 22546684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio Predict Severity and Prognosis of Lower Limb Arteriosclerosis Obliterans.
    Ye M; Qian X; Guo X; Wang H; Ni Q; Zhao Y; Xue G; Deng H; Zhang L
    Ann Vasc Surg; 2020 Apr; 64():221-227. PubMed ID: 31655109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Relationship Between the Neutrophil-Lymphocyte Ratio and In-Stent Restenosis in Patients With Femoropopliteal Chronic Total Occlusions.
    Chang Z; Zheng J; Liu Z; Guo Q
    Angiology; 2018 Feb; 69(2):177-182. PubMed ID: 28635304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Edge Stenosis After Covered Stenting for Long Superficial Femoral Artery Occlusive Disease: Risk Factor Analysis and Prevention With Drug-Coated Balloon Angioplasty.
    Lin TC; Huang CY; Chen PL; Lee CY; Shih CC; Chen IM
    J Endovasc Ther; 2018 Jun; 25(3):313-319. PubMed ID: 29673299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Drug-Eluting Stent Implantation for Femoropopliteal In-Stent Occlusion.
    Tomoi Y; Soga Y; Iida O; Shiraki T; Kobayashi Y; Hiramori S; Ando K
    J Endovasc Ther; 2016 Jun; 23(3):461-7. PubMed ID: 27004496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duplex criteria for in-stent restenosis in the superficial femoral artery.
    Kawarada O; Higashimori A; Noguchi M; Waratani N; Yoshida M; Fujihara M; Yokoi Y; Honda Y; Fitzgerald PJ
    Catheter Cardiovasc Interv; 2013 Mar; 81(4):E199-205. PubMed ID: 22639187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and Predictors of In-stent Re-Stenosis in the Superficial Femoral Artery: Evaluation of Long-Term Outcomes by Color Duplex Ultrasound.
    Gao M; Zhao X; Tao Y; Wang L; Xia M; Tong Z; Hou C; Hua Y
    Ultrasound Med Biol; 2016 Mar; 42(3):717-26. PubMed ID: 26678156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship Between Neutrophil-Lymphocyte Ratio and Drug-Coated Balloon Restenosis in Patients With Femoropopliteal Arterial Disease.
    Pan T; Tian SY; Liu Z; Zhang T; Li C; Ji DH; Wang F
    Angiology; 2023 Mar; 74(3):252-258. PubMed ID: 35575010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Classification and clinical impact of restenosis after femoropopliteal stenting.
    Tosaka A; Soga Y; Iida O; Ishihara T; Hirano K; Suzuki K; Yokoi H; Nanto S; Nobuyoshi M
    J Am Coll Cardiol; 2012 Jan; 59(1):16-23. PubMed ID: 22192663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of IVUS-Derived Vessel Size on Midterm Outcomes After Stent Implantation in Femoropopliteal Lesions.
    Miki K; Fujii K; Tanaka T; Yanaka K; Yoshihara N; Nishimura M; Sumiyoshi A; Horimatsu T; Imanaka T; Fukunaga M; Akahori H; Masuyama T; Ishihara M
    J Endovasc Ther; 2020 Feb; 27(1):77-85. PubMed ID: 31948376
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug-Eluting Stent vs Percutaneous Transluminal Angioplasty for Treatment of Femoropopliteal In-Stent Restenosis: Results From a Retrospective 1-Year Multicenter Study.
    Murata N; Takahara M; Soga Y; Nakano M; Yamauchi Y; Zen K; Kawasaki D; Yokoi H; Tosaka A; Tanaka N; Iida O
    J Endovasc Ther; 2016 Aug; 23(4):642-7. PubMed ID: 27099284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutrophil to Lymphocyte Ratio as a Predictor of Restenosis After Angioplasty and Stenting for Asymptomatic Carotid Stenosis.
    Dai Z; Li R; Zhao N; Han Y; Wang M; Zhang S; Bai Y; Li Z; Liang M; Xiao L; Ma M; Liu X; Xu G
    Angiology; 2019 Feb; 70(2):160-165. PubMed ID: 29940783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.